Healthcare -
Biotechnology - NASDAQ - US
$ 7.37
3.08 %
$ 365 M
Market Cap
-1.47
P/E
RGNX - OTHER CURRENT LIABILITIES
Other Current Liabilities RGNX - REGENXBIO Inc.
100 M
LAST VALUE
-0.32%
2 YEAR CAGR
43.57%
5 YEAR CAGR
39.10%
10 YEAR CAGR